Transcriptional Regulation by PHGDH Drives Amyloid Pathology in Alzheimer’S Disease

Researchers showed that altered expression of the late-onset Alzheimer’s disease (AD) biomarker phosphoglycerate dehydrogenase (PHGDH) modulates AD pathology in mice and human brain organoids independent of its enzymatic activity.